QUANTITY | PRIC PER pellet | SAVE AMOUNT |
---|---|---|
3 to 4 | EUR 8.00 /pellet | 0% |
5 to 9 | EUR 7.20 /pellet | 10% |
10 to 19 | EUR 6.00 /pellet | 25% |
20 to 29 | EUR 5.60 /pellet | 30% |
30 to 49 | EUR 5.20 /pellet | 35% |
50 to 99 | EUR 4.80 /pellet | 40% |
100 + | EUR 4.00 /pellet | 50% |
POPULAR PRODUCT
Many customers bought this product recently.
1BZ-LSD, or 1-benzyl-lysergic acid diethylamide, is a synthetic derivative of LSD (lysergic acid diethylamide). It belongs to the class of compounds known as lysergamides, which are characterized by their complex interactions with serotonin receptors in the brain. The compound was first synthesized in the early 2000s and has since been studied for its unique properties and effects.
The chemical structure of 1BZ-LSD is similar to that of LSD, with a benzyl group attached to the nitrogen atom at the 1-position of the indole ring. This modification is believed to influence the compound's pharmacological profile, potentially altering its potency, duration of effects, and side effect profile compared to its more well-known counterpart, LSD.
Users of 1BZ-LSD report a range of effects that are reminiscent of traditional psychedelics. These effects can include:
The onset of effects typically occurs within 30 to 90 minutes after ingestion, with a duration that can last anywhere from 6 to 12 hours, depending on the dose and individual metabolism.
As with many psychedelics, there is growing interest in the potential therapeutic applications of 1BZ-LSD. Preliminary research suggests that psychedelics may have benefits for various mental health conditions, including:
While research on 1BZ-LSD specifically is still in its infancy, the broader category of psychedelics has garnered attention for its potential to revolutionize mental health treatment.
In terms of safety, while 1BZ-LSD is generally considered to have a low toxicity profile, the lack of extensive research means that potential long-term effects and risks are not fully understood. As with any psychedelic, responsible use, including proper set and setting, is crucial to minimize risks.
1BZ-LSD represents an exciting development in the world of psychedelics, offering a unique profile that may contribute to our understanding of these powerful compounds. As research continues to unfold, it is essential to approach this substance with caution and respect, recognizing both its potential benefits and the need for further study. The future of psychedelics in mental health treatment is promising, and 1BZ-LSD may play a role in that evolving narrative.
1Bz-LSD 220mcg Pellets is for research use only and not intended for human consumption!
1Bz-LSD 220mcg Pellets stock last updated at: April 2025